| Business Name: |
Calla-Gampong Venus S MD |
| Contact Person: |
Venus Calla-Gampong, |
| Address: |
7622 250th St, Bellerose, New York 11426 |
| Phone Number: |
(917) 531-2723 |
| Annual Revenue (USD): |
$500.000 to $999.999 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
6211110 |
| Share This Business: |
|
| Related Businesses: |
New York Medical Rehab P C - Bellerose, NY 11426
Clemens Mandel MD - Bellerose, NY 11426
Crisostomo Eugenio MD - Bellerose, NY 11426
Sabapathy Hema MD - Bellerose, NY 11426
Josephine Panotes Md - Bellerose, NY 11426
Motamed Mehran MD - Bellerose, NY 11426
Singh Kabul MD - Bellerose, NY 11426
Amigo Nancy MD - Bellerose, NY 11426
Tasso Silvio MD - Bellerose, NY 11426
L I Gastroenterology Group Pc - Bellerose, NY 11426
Mesidor Rose-Lodie MD - Bellerose, NY 11426
Jurkowicz Abel MD - Bellerose, NY 11426
Morgenthal Alan D MD - Bellerose, NY 11426
Ideyi Steve C MD - Bellerose, NY 11426
Yousef Essam MD - Bellerose, NY 11426
Ogunlesi Christianah MD - Bellerose, NY 11426
Pulmonary Critical Care - Bellerose, NY 11426
Family Medical Health - Bellerose, NY 11426
Anand B Kul - Bellerose, NY 11426
Leroy Herbert M D P C - Bellerose, NY 11426
|
The company Calla-Gampong Venus S MD provides B2C services in the form of Doctors from its single location in New York.
1 to 4 employees work for Calla-Gampong Venus S MD, and the business now earns $500.000 to $999.999 per annum.
Calla-Gampong Venus S MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Calla-Gampong Venus S MD, please call Venus Calla-Gampong, with the phone number (917) 531-2723 or visit its single location at 7622 250th St in Bellerose, New York 11426.
The location of the single location can also be found using the coordinates 40.726694,-73.714906.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.